logo-loader
RNS
Advanced Medical Solutions Group

Adv Medical Soln Grp - Result of AGM

RNS Number : 2905B
Advanced Medical Solutions Grp PLC
05 June 2019
 

5 June 2019

Advanced Medical Solutions Group plc

("AMS" or the "Group")

 

Result of Annual General Meeting

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that at the Company's Annual General Meeting held today at 11am at the Guildhall Room, 85 Gresham Street, London, EC2V 7NQ, all resolutions were duly passed. Further details of each of the resolutions are set out in the Notice of Meeting, which was sent to shareholders on 30 April 2019.

 

Details of proxy votes received prior to the meeting will be made available on the Company's website at www.admedsol.com. The poll results were as follows.

 

Resolution

 

For (see note 2)

Against (see note 2)

No. of shares

%

No. of shares

%

1

113,452,786

99.99

6,557

0.01

2

108,651,443

95.58

5,019,580

4.42

3

112,970,753

99.39

697,545

0.61

4

112,732,404

99.17

947,555

0.83

5

82,188,882

78.56

22,436,168

21.44

6

108,803,775

98.06

2,149,910

1.94

7

113,581,749

99.91

100,000

0.09

8

87,994,990

77.99

24,831,007

22.01

9

113,450,700

99.86

156,688

0.14

10*

112,116,988

98.64

1,546,482

1.36

11*

90,835,600

99.33

614,373

0.67

*Special Resolution

- Ends -

 

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer




Consilium Strategic Communications

Tel: +44 (0) 20 3709 5700

Mary-Jane Elliott / Matthew Neal / Nicholas Brown / Olivia Manser

AMS@consilium-comms.com



Investec Bank PLC (NOMAD & Broker)

Tel: +44 (0) 20 7597 5970

Daniel Adams / Patrick Robb / Gary Clarence


 

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include tissue adhesives, sutures, biosurgical devices, internal sealants, silver alginates, alginates and foams, which it markets under its brands; LiquiBand®, LiquiBand® Fix 8™, RESORBA® and ActivHeal® as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Group has approximately 630 employees.  For more information, please see www.admedsol.com.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGSSWFMIFUSEEM
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read